| Name | CT-721 |
|---|
| Description | CT-721 is a potent and time-dependent Bcr-Abl kinase inhibitor with an IC50 of 21.3 nM for wild-type Bcr-Abl kinase, and possesses anti-chronic myeloid leukemia (CML) activities[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 21.3 nM (wild-type Bcr-Abl kinase)[1] |
| References |
| Molecular Formula | C30H29ClN6O |
|---|---|
| Molecular Weight | 525.04 |
| Hazard Codes | Xi |
|---|